News

CovidAsha, a chatbot platform on the Web, WhatsApp and Telegram, is a unique initiative by conversational automation heavy-weights Engati, and healthcare ecosystem players like Pharmeasy, VMedo, StanPlus and The Better India, with WhatsApp providing the platform. CovidAsha was born out...

Onyx Scientific, a small molecule API contract development and manufacturing organisation has received a commercial API license for its UK facility. The license, granted by the Medicines and Healthcare Products Regulatory Agency (MHRA), allows Onyx to support API projects from...

Iceni Diagnostics, a specialist carbohydrate chemistry company based in Norwich, is delighted to announce that it has agreed an exclusive global licence, to integrate key virus detection intellectual property (IP) developed by the University of Warwick, into its commercial...

India’s top drug regulator exempted foreign-made COVD-19 vaccines from post-approval bridging trials in the country, if they are approved by certain health bodies. According to the Indian Express, companies such as Pfizer and Cipla have asked for these exemptions during...

Cmed Technology has announced increased capabilities for encapsia, its advanced enterprise, cloud-based clinical data system, after increased demand for its use in decentralized trials. Encapsia delivers a complete solution to gather and manage multiple live clinical data sources and...

Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab,  announced that the company submitted an application to the US Food and Drug Administration (FDA) requesting...

Biological E has entered into an agreement with Canada-based Providence Therapeutics Holdings, to manufacture the latter’s mRNA (messenger Ribonucleic acid) vaccine PTX-COVID19-B in India. According to a release from the city-based vaccine maker, Biological E will be responsible for...